Richa Poddar - Feb 14, 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Chief Commercial Officer
Signature
/s/ William Cook, as Attorney in Fact for Richa Poddar
Stock symbol
AGIO
Transactions as of
Feb 14, 2022
Transactions value $
-$17,995
Form type
4
Date filed
2/16/2022, 04:00 PM
Previous filing
Feb 14, 2022
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $0 +1.74K +116.41% $0.00 3.23K Feb 14, 2022 Direct F1
transaction AGIO Common stock Tax liability -$18K -590 -18.26% $30.50 2.64K Feb 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock units Options Exercise $0 -1.74K -50% $0.00 1.74K Feb 14, 2022 Common stock 1.74K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2 The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.